complete alpha minimum essential media (α-mem (Thermo Fisher)
Thermo Fisher is a verified supplier 
Thermo Fisher manufactures this product 
90
Structured Review
Thermo Fisher
complete alpha minimum essential media (α-mem
Complete Alpha Minimum Essential Media (α Mem, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/complete+alpha+minimum+essential+media+(%CE%B1-mem/pm39523223-72-14-20
Average 90 stars, based on 1 article reviews
Complete Alpha Minimum Essential Media (α Mem, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/complete+alpha+minimum+essential+media+(%CE%B1-mem/pm39523223-72-14-20
Average 90 stars, based on 1 article reviews
complete alpha minimum essential media (α-mem - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Cell Culture:Article Title: Metronidazole-laden silk fibroin methacrylated scaffolds for managing periapical lesions. Article Snippet: This study aimed to develop and characterize silk fibroin methacrylated/SilkMA electrospun scaffolds associated with metronidazole/MET to control infection in root-end resected periapical lesions while supporting bone regeneration.. SilkMA-based formulations (10% w/v) incorporating MET (0—control; 5, 15, or 30% w/w) were electrospun into fibrous scaffolds and photocrosslinked.. Scaffolds’ morphology, chemical composition, swelling/degradation profiles, mechanical properties, cytocompatibility with alveolar bone-derived mesenchymal stem cells/aBMSCs and stem cells from apical papilla/SCAPs, antiinflammatory potential, and antibacterial efficacy (direct contact assay against Aggregatibacter actinomycetemcomitans/Aa and Fusobacterium nucleatum/Fn; Aa biofilm model) were assessed. other:Article Title: Identification of novel fibroblast-like cells from stem cells from human exfoliated deciduous teeth. Article Snippet: Objectives This study aimed to differentiate and characterize fibroblast-like cells from stem cells from human exfoliated deciduous teeth (SHED).. Materials and methods The differentiation of fibroblast-like cells from SHED was carried out by using specific human recombinant connective tissue growth factor (CTGF).. To characterize fibroblastic differentiation, the induced cells were subjected to morphological changes, proliferation rate, gene expression analysis using quantitative reverse transcription-polymerase chain reaction (qRT-PCR), flow cytometry, and immunofluorescence staining. Article Title: Nanofibrous yet injectable polycaprolactone-collagen bone tissue scaffold with osteoprogenitor cells and controlled release of bone morphogenetic protein-2. Article Snippet: Contents lists available at ScienceDirect Materials Science and Engineering C j ourna l homepage: www.e lsev ie r .com/ locate /msec Nanofibrous yet injectable polycaprolactone-collagen bone tissue scaffold with osteoprogenitor cells and controlled release of bone morphogenetic protein-2 Gayathri Subramanian a, Callan Bialorucki a, Eda Yildirim-Ayan a,b,⁎ a Department of Bioengineering, College of Engineering, University of Toledo, Toledo, OH 43606, USA b Department of Orthopaedic Surgery, University of Toledo Medical Center, Toledo, OH 43614, USA ⁎ Corresponding author at: Department of Bioengine University of Toledo, Toledo, OH 43606, USA.. E-mail address: eda.yildirimayan@utoledo.edu (E. Yild http://dx.doi.org/10.1016/j.msec.2015.02.030 0928-4931/© 2015 Elsevier B.V. All rights reserved. a b s t r a c t a r t i c l e i n f o Article history: Received 30 October 2014 Received in revised form 21 January 2015 Accepted 23 February 2015 Available online 25 February 2015 Keywords: Injectable scaffold BMP-2 release Osteogenic differentiation Polycaprolactone Collagen type-I In this work, we developed a nanofibrous, yet injectable orthobiologic tissue scaffold that is capable of hosting osteoprogenitor cells and controlling kinetic release profile of the encapsulated pro-osteogenic factor without diminishing its bioactivity over 21 days.. This innovative injectable scaffold was synthesized by incorporating electrospun and subsequently O2 plasma-functionalized polycaprolactone (PCL) nanofibers within the collagen type-I solution along with MC3T3-E1 cells (pre-osteoblasts) and bone morphogenetic protein-2 (BMP2). |